MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Soluble urokinase-type plasminogen activator receptor (SuPAR) in patients with Parkinson’s disease

    N. Witek, J. Joyce, J. Hawkins, Y. Liu, B. Ouyang, R. Patel, J. Borgia, J. Reiser, D. Hall (Chicago, USA)

    Objective: The objective of this study was to assess if soluble urokinase-type plasminogen activator receptor (SuPAR) is elevated in patients with Parkinson's disease (PD). Background:…
  • MDS Virtual Congress 2021

    Belly Dancer’s Dyskinesia with Systemic Lupus Erythematosus: A Case Report

    EAJ. Hutabarat, NA. Santosa (Surakarta, Indonesia)

    Objective: To present a rare case of belly dancer’s dyskinesia with systemic lupus erythematosus (SLE). Background: Belly dancer’s dyskinesia is a rare disease caused by…
  • MDS Virtual Congress 2021

    Expanding the phenotypic spectrum of diabetic striatopathy: a case series

    N. Chunga, G. Schifitto, R. Ramchandran, A. Lang, K. Lizarraga (Rochester, USA)

    Objective: To illustrate the spectrum of diabetic striatopathy by presenting 3 cases with different clinical and neuroimaging findings. Background: Diabetic striatopathy is a rare complication…
  • MDS Virtual Congress 2021

    Health instruction in Parkinson’s disease with an emphasis on the quality of life using eHealth strategies in the context of COVID-19

    J. Biernaski, S. Souza, D. Baptista, M. Borato, N. Cuduh, J. Pelegrini, A. Silva, V. Israel (Curitiba, Paraná, Brazil)

    Objective: To develop an eHealth Physiotherapy Program (ePhysio) for remote health instruction to promote the quality of life (QOL) of people with Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    RISK FACTORS FOR FALLS AMONG PEOPLE WITH PARKINSON ʼS DISEASE

    T. Hernja Rumpf (Maribor, Slovenia)

    Objective: The aim of this study was to identify predictive risk factors for falls in patients with PB. Background: Parkinson's disease (PD) is a chronic,…
  • MDS Virtual Congress 2021

    Effectiveness of a novel cognitive rehabilitation program based on mindfulness and reminiscence in patients with Parkinson’s Disease and Mild Cognitive Impairment: a pilot study

    M. Reitano, M. Dini, F. Ruggiero, S. Tagini, F. Solca, B. Poletti, A. Priori, R. Ferrucci (Milan, Italy)

    Objective: To evaluate the efficacy of a new integrated rehabilitation program based on Mindfulness and Cognitive Training (MILC-tr) on cognitive functions and mood in patients…
  • MDS Virtual Congress 2021

    Caregiving in Parkinson’s Disease: An International Perspective

    E. Book, R. Dawson, A. Allen, L. Kapust, J. Mckenzie, M. Ueda, A. Yu (Vancouver, Canada)

    Objective: The objective of the focus group study was to gain insight into the role of informal and formal resources in supporting caregivers of people…
  • MDS Virtual Congress 2021

    Validation of the UCLA Loneliness Scale in Parkinson’s Disease During a Period of Social Distancing

    I. Subramanian, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: To examine the association between UCLA loneliness questionnaire (ULQ) scores and motor and non-motor symptoms (NMS) and Quality of Life (QoL) in Parkinson Disease…
  • MDS Virtual Congress 2021

    Childhood-Onset Hemidystonia: A Transportophaty related to SLC6A3 missense mutation

    G. Prado-Miranda, K. Salinas-Barboza, JM. Altamirano, AA. Alvarado-Bolaños (Mexico City, Mexico)

    Objective: To present the case of a childhood-onset hemidystonia carrying a homozygous SLC6A3 missense mutation. Background: Dystonia is a movement disorder characterized by sustained or…
  • MDS Virtual Congress 2021

    Maximising UPDRS information while minimising assessment time

    G. Morinan, J. Tang, J. O'Keeffe (London, United Kingdom)

    Objective: The gold standard for measuring disease severity in PD (Parkinson’s Disease) is the MDS-UPDRS (Movement Disorder Society - Unified PD Rating Scale) [1]. However,…
  • « Previous Page
  • 1
  • …
  • 122
  • 123
  • 124
  • 125
  • 126
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley